Kuehn Rebecca, Fong James, Taylor Richard, Gyaneshwar Rajanishwar, Carter Karen
School of Public Health and Community Medicine, Faculty of Medicine University of New South Wales, Sydney, NSW, Australia.
Aust N Z J Obstet Gynaecol. 2012 Aug;52(4):380-6. doi: 10.1111/j.1479-828X.2012.01461.x.
Previous studies indicate that cervical cancer is the second most frequent cancer and most common cause of cancer mortality among women in Fiji. There is little published data on the epidemiology of cervical cancer in Pacific countries.
To determine the incidence 2003-2009 of, and mortality 2003-2008 from, cervical cancer by ethnicity and period in Fiji, identify evidence of secular change and relate these data to other Pacific countries, Australia and New Zealand.
Counts of incident cervical cancer cases (2003-2009) and unit record mortality data (2003-2008) from the Fiji Ministry of Health were used to calculate age-standardised (to the WHO World Population) cervical cancer incidence and mortality rates, and cervical or uterine cancer mortality rates, by ethnicity, with 95% confidence intervals. On the basis of comparison of cervical cancer mortality with cervical or uterine cancer mortality in Fiji with similar populations, misclassification of cervical cancer deaths is unlikely.
There is no evidence of secular change in cervical cancer incidence and mortality rates for the study period. For women of all ages and ethnicities, the age-standardised incidence rate of cervical cancer (2003-2009) was 27.6 per 100,000 (95% CI 25.4-29.8) and the age-standardised mortality rate (2003-2008) was 23.9 per 100,000 (95% CI 21.5-26.4). The mortality/incidence ratio was 87%. Fijians had statistically significant higher age-standardised incidence and mortality rates than Indians. Fiji has one of the highest estimated rates of cervical cancer incidence and mortality in the Pacific region.
Cervical cancer screening in Fiji needs to be expanded and strengthened.
先前的研究表明，宫颈癌是斐济女性中第二常见的癌症，也是癌症死亡的最常见原因。关于太平洋国家宫颈癌流行病学的已发表数据很少。
确定2003 - 2009年斐济按种族和时期划分的宫颈癌发病率以及2003 - 2008年的死亡率，识别长期变化的证据，并将这些数据与其他太平洋国家、澳大利亚和新西兰进行比较。
利用斐济卫生部提供的宫颈癌发病病例数（2003 - 2009年）和单位记录死亡率数据（2003 - 2008年），按种族计算年龄标准化（以世界卫生组织世界人口为标准）的宫颈癌发病率和死亡率以及宫颈癌或子宫癌死亡率，并给出95%置信区间。基于斐济宫颈癌死亡率与类似人群中宫颈癌或子宫癌死亡率的比较，宫颈癌死亡的误分类不太可能发生。
在研究期间，没有证据表明宫颈癌发病率和死亡率有长期变化。对于所有年龄和种族的女性，宫颈癌年龄标准化发病率（2003 - 2009年）为每10万人27.6例（95%置信区间25.4 - 29.8），年龄标准化死亡率（2003 - 2008年）为每10万人23.9例（95%置信区间21.5 - 26.4）。死亡率/发病率比值为87%。斐济人的年龄标准化发病率和死亡率在统计学上显著高于印度人。斐济是太平洋地区宫颈癌发病率和死亡率估计最高的国家之一。
斐济的宫颈癌筛查需要扩大和加强。
